LocusLink | Affy Probe Set | Symbol | Unigene ID | Gene Name | Map | Var Imp |
---|---|---|---|---|---|---|
29760 | 38242_at | BLNK | Hs.444049 | B-cell linker | 10q23.2-q23.33 | 0.606536 |
3932 | 33238_at | LCK | Hs.470627 | lymphocyte-specific protein tyrosine kinase | 1p34.3 | 0.574051 |
3122 | 37039_at | HLA-DRA | Hs.520048 | major histocompatibility complex, class II, DR alpha | 6p21.3 | 0.547618 |
3932 | 2059_s_at | LCK | Hs.470627 | lymphocyte-specific protein tyrosine kinase | 1p34.3 | 0.542744 |
974 | 37988_at | CD79B | Hs.89575 | CD79B antigen (immunoglobulin-associated beta) | 17q23 | 0.531337 |
972 | 35016_at | CD74 | Hs.436568 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 5q32 | 0.502854 |
3115 | 38095_i_at | HLA-DPB1 | Hs.485130 | major histocompatibility complex, class II, DP beta 1 | 6p21.3 | 0.496963 |
915 | 38319_at | CD3D | Hs.504048 | CD3D antigen, delta polypeptide (TiT3 complex) | 11q23 | 0.485887 |
50852 | 33039_at | TRAT1 | Hs.138701 | T cell receptor associated transmembrane adaptor 1 | 3q13 | 0.482858 |
3115 | 38096_f_at | HLA-DPB1 | Hs.485130 | major histocompatibility complex, class II, DP beta 1 | 6p21.3 | 0.450812 |
3108 | 37344_at | HLA-DMA | Hs.351279 | major histocompatibility complex, class II, DM alpha | 6p21.3 | 0.420408 |
4068 | 38147_at | SH2D1A | Hs.349094 | SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) | Xq25-q26 | 0.414836 |
928 | 39389_at | CD9 | Hs.114286 | CD9 antigen (p24) | 12p13.3 | 0.405348 |
3109 | 41609_at | HLA-DMB | Hs.1162 | major histocompatibility complex, class II, DM beta | 6p21.3 | 0.395638 |
917 | 39226_at | CD3G | Hs.2259 | CD3G antigen, gamma polypeptide (TiT3 complex) | 11q23 | 0.395425 |
8531 | 39839_at | CSDA | Hs.221889 | cold shock domain protein A | 12p13.1 | 0.393652 |
23062 | 40278_at | GGA2 | Hs.460336 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 16p12 | 0.393636 |
3507 | 41165_g_at | IGHM | Hs.510635 Hs.525648 Hs.555796 | immunoglobulin heavy constant mu | 14q32.33 | 0.393025 |
930 | 1096_g_at | CD19 | Hs.96023 | CD19 antigen | 16p11.2 | 0.371776 |
3113 | 38833_at | HLA-DPA1 | Hs.347270 | major histocompatibility complex, class II, DP alpha 1 | 6p21.3 | 0.370935 |
2308 | 40570_at | FOXO1A | Hs.370666 | forkhead box O1A (rhabdomyosarcoma) | 13q14.1 | 0.368394 |
3119 | 36773_f_at | HLA-DQB1 | Hs.409934 Hs.520049 Hs.533252 | major histocompatibility complex, class II, DQ beta 1 | 6p21.3 | 0.356872 |
919 | 37078_at | CD3Z | Hs.156445 | CD3Z antigen, zeta polypeptide (TiT3 complex) | 1q22-q23 | 0.356664 |
6964 | 38917_at | TRD@ | Hs.512047 | T cell receptor delta locus | 14q11.2 | 0.355486 |
9473 | 41409_at | C1orf38 | Hs.10649 | chromosome 1 open reading frame 38 | 1p35.3 | 0.354404 |
5588 | 38949_at | PRKCQ | Hs.498570 | protein kinase C, theta | 10p15 | 0.354077 |
3119 | 36878_f_at | HLA-DQB1 | Hs.409934 Hs.520049 Hs.533252 | major histocompatibility complex, class II, DQ beta 1 | 6p21.3 | 0.353225 |
6932 | 32649_at | TCF7 | Hs.519580 | transcription factor 7 (T-cell specific, HMG-box) | 5q31.1 | 0.347422 |
3507 | 41164_at | IGHM | Hs.510635 Hs.525648 Hs.555796 | immunoglobulin heavy constant mu | 14q32.33 | 0.34497 |
6415 | 39709_at | SEPW1 | Hs.529132 | selenoprotein W, 1 | 19q13.3 | 0.342555 |
6964 | 1110_at | TRD@ | Hs.512047 | T cell receptor delta locus | 14q11.2 | 0.333914 |
3142 | 599_at | HLX1 | Hs.74870 | H2.0-like homeo box 1 (Drosophila) | 1q41-q42.1 | 0.320114 |
4925 | 35643_at | NUCB2 | Hs.128686 | nucleobindin 2 | 11p15.1-p14 | 0.319844 |
7535 | 1498_at | ZAP70 | Hs.234569 | zeta-chain (TCR) associated protein kinase 70kDa | 2q12 | 0.290889 |
973 | 38017_at | CD79A | Hs.79630 | CD79A antigen (immunoglobulin-associated alpha) | 19q13.2 | 0.28969 |
3127 | 41723_s_at | HLA-DRB5 | Hs.534322 | major histocompatibility complex, class II, DR beta 5 | 6p21.3 | 0.288572 |
3125 | 33261_at | HLA-DRB3 | Hs.520049 Hs.534322 Hs.554754 | major histocompatibility complex, class II, DR beta 3 | 6p21.3 | 0.275855 |
1495 | 41156_g_at | CTNNA1 | Hs.445981 | catenin (cadherin-associated protein), alpha 1, 102kDa | 5q31 | 0.27294 |
5588 | 2081_s_at | PRKCQ | Hs.498570 | protein kinase C, theta | 10p15 | 0.267572 |
10868 | 36473_at | USP20 | Hs.5452 | ubiquitin specific peptidase 20 | 9q34.11 | 0.263915 |
60481 | 33821_at | ELOVL5 | Hs.520189 | ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) | 6p21.1-p12.1 | 0.262919 |
1026 | 2031_s_at | CDKN1A | Hs.370771 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 6p21.2 | 0.254913 |
5142 | 33705_at | PDE4B | Hs.198072 | phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) | 1p31 | 0.250905 |
8115 | 39318_at | TCL1A | Hs.2484 | T-cell leukemia/lymphoma 1A | 14q32.1 | 0.246177 |
23362 | 35794_at | PSD3 | Hs.434255 | pleckstrin and Sec7 domain containing 3 | 8pter-p23.3 | 0.245963 |
7805 | 37759_at | LAPTM5 | Hs.371021 | lysosomal associated multispanning membrane protein 5 | 1p34 | 0.244968 |
6643 | 41462_at | SNX2 | Hs.134822 | sorting nexin 2 | 5q23 | 0.243988 |
3709 | 33839_at | ITPR2 | Hs.512235 | inositol 1,4,5-triphosphate receptor, type 2 | 12p11 | 0.237731 |
2022 | 32562_at | ENG | Hs.76753 | endoglin (Osler-Rendu-Weber syndrome 1) | 9q33-q34.1 | 0.23748 |
933 | 38521_at | CD22 | Hs.262150 | CD22 antigen | 19q13.1 | 0.237216 |
6284 | 39712_at | S100A13 | Hs.516505 | S100 calcium binding protein A13 | 1q21 | 0.23503 |
27040 | 40688_at | LAT | Hs.498997 | linker for activation of T cells | 16p11.2 | 0.222958 |
3507 | 41166_at | IGHM | Hs.510635 Hs.525648 Hs.555796 | immunoglobulin heavy constant mu | 14q32.33 | 0.217432 |
1490 | 36638_at | CTGF | Hs.410037 | connective tissue growth factor | 6q23.1 | 0.214948 |
55966 | 39575_at | AJAP1 | Hs.25924 | adherens junction associated protein 1 | 1p36.32 | 0.212195 |
1117 | 31891_at | CHI3L2 | Hs.514840 | chitinase 3-like 2 | 1p13.3 | 0.206115 |
10962 | 36941_at | MLLT11 | Hs.75823 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) translocated to, 11 | 1q21 | 0.204724 |
3709 | 756_at | ITPR2 | Hs.512235 | inositol 1,4,5-triphosphate receptor, type 2 | 12p11 | 0.200715 |
9760 | 33316_at | TOX | Hs.491805 | NA | 8q12.1 | 0.200463 |
1839 | 38037_at | HBEGF | Hs.799 | heparin-binding EGF-like growth factor | 5q23 | 0.199061 |
10123 | 39829_at | ARL7 | Hs.111554 | ADP-ribosylation factor-like 7 | 2q37.1 | 0.198934 |
4852 | 38604_at | NPY | Hs.1832 | neuropeptide Y | 7p15.1 | 0.198826 |
51232 | 40936_at | CRIM1 | Hs.332847 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 2p21 | 0.193914 |
11027 | 34033_s_at | LILRA2 | Hs.546340 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | 19q13.4 | 0.192558 |
934 | 266_s_at | CD24 | Hs.375108 | CD24 antigen (small cell lung carcinoma cluster 4 antigen) | 6q21 | 0.191686 |
2934 | 32612_at | GSN | Hs.522373 | gelsolin (amyloidosis, Finnish type) | 9q33 | 0.188744 |
6957 | 32794_g_at | TRB@ | NA | T cell receptor beta locus | 7q34 | 0.187281 |
8073 | 1241_at | PTP4A2 | Hs.470477 | protein tyrosine phosphatase type IVA, member 2 | 1p35 | 0.178729 |
1495 | 2085_s_at | CTNNA1 | Hs.445981 | catenin (cadherin-associated protein), alpha 1, 102kDa | 5q31 | 0.178638 |
1495 | 41155_at | CTNNA1 | Hs.445981 | catenin (cadherin-associated protein), alpha 1, 102kDa | 5q31 | 0.176956 |
28619 | 1105_s_at | TRBV3-1 | Hs.555941 | T cell receptor beta variable 3-1 | 7q34 | 0.171723 |
9124 | 36937_s_at | PDLIM1 | Hs.368525 | PDZ and LIM domain 1 (elfin) | 10q22-q26.3 | 0.169399 |
26469 | 33453_at | PTPN18 | Hs.516390 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) | 2q21.1 | 0.166767 |
6993 | 946_at | TCTEL1 | Hs.445999 | t-complex-associated-testis-expressed 1-like 1 | 6q25.2-q25.3 | 0.16452 |
7029 | 34741_at | TFDP2 | Hs.379018 | transcription factor Dp-2 (E2F dimerization partner 2) | 3q23 | 0.160906 |